Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling

[1]  A. Reddy,et al.  Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts. , 2010, Bone.

[2]  Kristina Kapinas,et al.  miR‐29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical Wnt signaling , 2009, Journal of cellular biochemistry.

[3]  Michael M. Wang,et al.  Thrombospondin 2 Potentiates Notch3/Jagged1 Signaling* , 2009, Journal of Biological Chemistry.

[4]  Stan Gronthos,et al.  The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair , 2009, Journal of cellular physiology.

[5]  S. Goldstein,et al.  Thrombospondin-2 Influences the Proportion of Cartilage and Bone During Fracture Healing , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  W. Sessa,et al.  Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. , 2008, The American journal of pathology.

[7]  V. Jorgetti,et al.  Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. , 2008, Bone.

[8]  J. Lawler,et al.  Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. , 2008, The American journal of pathology.

[9]  R. Chiusaroli,et al.  Doubly Truncated FosB Isoform (Δ2ΔFosB) Induces Osteosclerosis in Transgenic Mice and Modulates Expression and Phosphorylation of Smads in Osteoblasts Independent of Intrinsic AP‐1 Activity , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Tatsuya Kobayashi,et al.  Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation , 2008, Nature Medicine.

[11]  Yongwon Choi,et al.  Osteoimmunology: interactions of the bone and immune system. , 2008, Endocrine reviews.

[12]  D. McMahon,et al.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis , 2008, Osteoporosis International.

[13]  S. Evans,et al.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. , 2007, Physiological genomics.

[14]  Sergey Plotnikov,et al.  Second harmonic generation imaging microscopy studies of osteogenesis imperfecta. , 2007, Journal of biomedical optics.

[15]  Andrea Giustina,et al.  Mechanisms of anabolic therapies for osteoporosis. , 2007, The New England journal of medicine.

[16]  Hoguen Kim,et al.  Frequent inactivation of SPARC by promoter hypermethylation in colon cancers , 2007, International journal of cancer.

[17]  B. Dai,et al.  SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron. , 2007, Biochemical and biophysical research communications.

[18]  A. Delany,et al.  Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. , 2007, Endocrinology.

[19]  C. Miller,et al.  Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response , 2007, Genes and Immunity.

[20]  K. Nagashima,et al.  Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts , 2007, Journal of cellular physiology.

[21]  강현주,et al.  Frequent inactivation of SPARC by promoter hypermethylation in colon cancers , 2007 .

[22]  A. Alford,et al.  Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. , 2006, Bone.

[23]  P. Delmas,et al.  Bone quality--the material and structural basis of bone strength and fragility. , 2006, The New England journal of medicine.

[24]  Sundar Srinivasan,et al.  Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading. , 2006, Bone.

[25]  Chen Zhao,et al.  Reduced Expression of Thrombospondins and Craniofacial Dysmorphism in Mice Overexpressing Fra1 , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Hector F Rios,et al.  DMP1 Depletion Decreases Bone Mineralization In Vivo: An FTIR Imaging Analysis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  S. Dedhar,et al.  SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity* , 2005, Journal of Biological Chemistry.

[28]  S. Nilsson,et al.  Stem Cell Regulation by the Haemopoietic Stem Cell Niche , 2005, Cell cycle.

[29]  C. Stuelten,et al.  Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells* , 2005, Journal of Biological Chemistry.

[30]  P. Bornstein,et al.  Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[31]  Kurt D. Hankenson,et al.  Mice with a Disruption of the Thrombospondin 3 Gene Differ in Geometric and Biomechanical Properties of Bone and Have Accelerated Development of the Femoral Head , 2005, Molecular and Cellular Biology.

[32]  K. Kokini,et al.  Biomechanics and Mechanotransduction in Cells and Tissues Extracellular matrix ( ECM ) microstructural composition regulates local cell-ECM biomechanics and fundamental fibroblast behavior : a multidimensional perspective , 2005 .

[33]  Shuang Huang,et al.  Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability , 2005, Cell.

[34]  R. Borojevic,et al.  Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations , 2005, Cell and Tissue Research.

[35]  R. Duisters,et al.  Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy , 2004, Circulation research.

[36]  D. Bartel,et al.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.

[37]  R. Chiusaroli,et al.  ΔFosB Induces Osteosclerosis and Decreases Adipogenesis by Two Independent Cell-Autonomous Mechanisms , 2004, Molecular and Cellular Biology.

[38]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[39]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[40]  M. Castellazzi,et al.  v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3 , 2003, Oncogene.

[41]  I. Kalajzic,et al.  Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. , 2003, Endocrinology.

[42]  A. Boskey,et al.  Infrared Analysis of the Mineral and Matrix in Bones of Osteonectin‐Null Mice and Their Wildtype Controls , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  K. Kaushansky,et al.  Megakaryocytes require thrombospondin-2 for normal platelet formation and function. , 2003, Blood.

[44]  P. Bornstein,et al.  The Secreted Protein Thrombospondin 2 Is an Autocrine Inhibitor of Marrow Stromal Cell Proliferation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  Sundar Srinivasan,et al.  Noninvasive Loading of the Murine Tibia: An In Vivo Model for the Study of Mechanotransduction , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  A. Barbero,et al.  Real‐time quantitative RT‐PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro , 2002, Journal of cellular biochemistry.

[47]  A. Boskey,et al.  Osteopontin Deficiency Increases Mineral Content and Mineral Crystallinity in Mouse Bone , 2002, Calcified Tissue International.

[48]  J. Lawler.  The functions of thrombospondin-1 and-2. , 2000, Current opinion in cell biology.

[49]  M. Amling,et al.  Osteopenia and decreased bone formation in osteonectin-deficient mice , 2000, The Journal of clinical investigation.

[50]  S. Goldstein,et al.  Increased Marrow‐Derived Osteoprogenitor Cells and Endosteal Bone Formation in Mice Lacking Thrombospondin 2 , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  M. Young,et al.  Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone , 2000, Journal of cellular biochemistry.

[52]  M. Detmar,et al.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Bornstein,et al.  Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. , 1999, The Journal of investigative dermatology.

[54]  S. Wagstaff,et al.  Expression of members of the thrombospondin family by human skeletal tissues and cultured cells. , 1999, Biochemical and biophysical research communications.

[55]  J. Aubin,et al.  Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro , 1999, Journal of cellular biochemistry.

[56]  S. K. Lee,et al.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. , 1999, Endocrinology.

[57]  P. Bornstein,et al.  The Distribution of the Matricellular Protein Thrombospondin 2 in Tissues of Embryonic and Adult Mice , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[58]  M. Simons,et al.  Myb-dependent Regulation of Thrombospondin 2 Expression , 1998, The Journal of Biological Chemistry.

[59]  R. Hynes,et al.  Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.

[60]  E. Canalis,et al.  Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. , 1998, American journal of physiology. Cell physiology.

[61]  E. Ginns,et al.  Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis , 1998, The Journal of cell biology.

[62]  R. Hynes,et al.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo. , 1998, Cell.

[63]  P. Bornstein,et al.  Analysis of the promoter and transcription start sites of the human thrombospondin 2 gene (THBS2). , 1997, Gene.

[64]  K. Oritani,et al.  Identification of stromal cell products that interact with pre-B cells , 1996, The Journal of cell biology.

[65]  T. Krieg,et al.  A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[66]  G S Stein,et al.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.

[67]  M. Iruela-Arispe,et al.  Differential expression of thrombospondin 1, 2, and 3 during murine development , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[68]  R. Brenner,et al.  Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  F. W. Wolf,et al.  Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. , 1992, The Journal of biological chemistry.

[70]  G. Stein,et al.  Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[71]  C. Disteche,et al.  A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Hefferan,et al.  Expression of the osteonectin gene potentially controlled by multiple Cis‐ and trans‐acting factors in cultured bone cells , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[73]  J. Guénet,et al.  Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. , 1991, Bone.

[74]  M. Young,et al.  Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts. , 1989, Molecular endocrinology.

[75]  J. Wrana,et al.  Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations , 1988, The Journal of cell biology.

[76]  N. Tuross,et al.  The Mr 24,000 phosphoprotein from developing bone is the NH2-terminal propeptide of the alpha 1 chain of type I collagen. , 1987, The Journal of biological chemistry.

[77]  F. Kuwata,et al.  Identification of pre-osteonectin produced by cell-free translation of fetal porcine calvarial mRNA. , 1985, The Journal of biological chemistry.

[78]  K. Thompson,et al.  Osteonectin, bone proteoglycan, and phosphophoryn defects in a form of bovine osteogenesis imperfecta. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Rudolph.  Fetal and neonatal pulmonary circulation. , 1977, The American review of respiratory disease.